GlassScriptPhysician profile
Caleb James Ortega
NPI 1679983050
$7,531.47
in general payments reported to CMS, 2019-2025
26 companies · $813 in 2025
The $813 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,378 · 2020: $424 · 2021: $673 · 2022: $340 · 2023: $1,201 · 2024: $1,702 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,360 · Travel and Lodging: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,359.57 |
| Travel and Lodging | $1,356.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,970.59 | 2019-2020 | |
| Nevro Corp. | $1,141.53 | 2019-2024 | Senza |
| Medtronic, INC. | $1,043.83 | 2021-2025 | Activos 10 Bone Cement, Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $875.38 | 2019-2025 | Proclaim, Prodigy |
| Boston Scientific Corporation | $610.27 | 2021-2024 | Intracept |
| Relievant Medsystems, INC. | $500.17 | 2022-2023 | Intracept |
| Abbvie INC. | $328.67 | 2022-2025 | |
| Globus Medical, INC. | $272.39 | 2025 | Senza, Vyrsa V1, Vyrsa V1 |
| Vertiflex, INC. | $106.07 | 2019 | |
| Allergan, INC. | $97.37 | 2021-2022 | |
| Amgen INC. | $76.50 | 2021-2022 | |
| Bioventus LLC | $73.34 | 2025 | Xcell, Durolane, Gelsyn-3 |
| Stryker Corporation | $60.23 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Ibsa Pharma INC. | $46.59 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $43.15 | 2021 | |
| Vertos Medical, INC. | $40.34 | 2023-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $37.88 | 2024-2025 | Belbuca |
| Merz Pharmaceuticals, LLC | $31.33 | 2025 | Xeomin |
| Si-Bone, INC. | $26.68 | 2024 | |
| Zak Ortho | $23.05 | 2025 | |
| Spr Therapeutics, INC | $18.83 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.69 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $15.60 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.61 | 2022 | |
| Radius Health, INC. | $12.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Ortega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.